Insider buying
~$23K5,000 sh @ $4.67
Traded Jul 2, 2025 · filed 5 days later
Since the trade −33.2% · S&P 500 +15.4% · to Nov 19
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Checked for new insider filings 5 min ago
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Open-market purchases by insiders.
Insider buying
Traded Jul 2, 2025 · filed 5 days later
Since the trade −33.2% · S&P 500 +15.4% · to Nov 19
Lately at Nexpoint Diversified Real Estate Trust: the stock fell 18% in one session on Oct 29; the stock is down 35% in 30 days.
Insider buying
Traded Jul 3, 2025 · filed 4 days later
Since the trade −22.6% · S&P 500 +14.5% · to Nov 19
A major shareholder of Texas Pacific Land paid $1.1K out of pocket for Texas Pacific Land shares. 1 other person at Texas Pacific Land bought some too, in the same month.
Lately at Texas Pacific Land Corporation: the stock fell 13% in one session on Nov 4 around a company release; it reported its results on Nov 4; the stock is down 19% in 30 days.
Insider buying
Traded Jul 7, 2025 · filed the same day
Since the trade −33.3% · S&P 500 +15.3% · to Nov 19
The CEO of Dolphin Entertainment paid $5K out of pocket for Dolphin Entertainment shares.
Lately at Dolphin Entertainment: it reported its results on Nov 10; the stock is down 7% in 30 days.
Traded Jul 1, 2025 · largest single transaction ~$259
Lately at Jupiter Neurosciences: the stock is down 48% in 30 days.
Jul 1, 2025~$257 · 250 sh @ $1.03
DetailsOfficial recordJul 1, 2025~$259 · 250 sh @ $1.03
DetailsOfficial recordJul 1, 2025~$257 · 250 sh @ $1.03
DetailsOfficial recordInsider buying
Open-market purchases, traded Jun 30, 2025. Each amount is that person's own.
Two of these filings report the same value. Joint filers can report the same shares, so the amounts are not added up.
Lately at Biocardia: it received a notice from its stock exchange on Nov 20; the stock is down 26% in 30 days.
Insider buying
Open-market purchases, traded Jul 2, 2025. Each amount is that person's own.
Two of these filings report the same value. Joint filers can report the same shares, so the amounts are not added up.
Lately at Cellectar Biosciences: it reported its results on Nov 10; the stock is down 28% in 30 days.
Insider buying
Traded Jul 1, 2025 · filed 2 days later
Since the trade +89.1% · S&P 500 +15.9% · to Nov 19
A major shareholder of Neuraxis paid $800K out of pocket for Neuraxis shares. Shares held went up 46% with this purchase.
Lately at Neuraxis: the stock fell 11% in one session on Nov 5; the stock is down 42% in 30 days.
Traded Jul 1 – Jul 2, 2025 · largest single transaction ~$3.06M
Lately at Asana: it signed an important agreement on Nov 10; the stock is down 17% in 30 days.
Jul 2, 2025~$3.06M · 225K sh @ $13.61
DetailsOfficial recordJul 1, 2025~$3.06M · 225K sh @ $13.58
DetailsOfficial recordTraded Jul 1 – Jul 2, 2025 · largest single transaction ~$25K
Lately at Immuneering: it changed a top executive or board member on Nov 9; the stock is down 8% in 30 days.
Jul 2, 2025~$25K · 7,015 sh @ $3.53
DetailsOfficial recordJul 1, 2025~$10K · 2,985 sh @ $3.38
DetailsOfficial recordInsider buying
Traded Jul 1, 2025 · filed 2 days later
Since the trade −19.5% · S&P 500 +15.9% · to Nov 19
The CEO of Culp paid $50K out of pocket for Culp shares. Shares held went up 13% with this purchase.
Lately at Culp: the stock is down 17% in 30 days; insiders made 3 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Jul 1, 2025 · filed 2 days later
Since the trade −85.0% · S&P 500 +15.9% · to Nov 19
Calcimedica's Chief Scientific Officer paid $1.9K out of pocket for Calcimedica shares. 4 other people at Calcimedica bought some too, in the same month. It was the first purchase in over a year.
Lately at Calcimedica: it reported its results on Nov 10; the stock is up 10% in 30 days.